Use of sulfadiazine in the prophylaxis of group A meningococcal carriers in Egypt
- PMID: 4208558
Use of sulfadiazine in the prophylaxis of group A meningococcal carriers in Egypt
Similar articles
-
Prevalence of Neisseria meningitidis serogroups in Egypt.Trop Geogr Med. 1973 Dec;25(4):350-4. Trop Geogr Med. 1973. PMID: 4206822 No abstract available.
-
The carrier state: Neisseria meningitidis.J Antimicrob Chemother. 1986 Jul;18 Suppl A:25-34. doi: 10.1093/jac/18.supplement_a.25. J Antimicrob Chemother. 1986. PMID: 3091563 No abstract available.
-
Efficacy of rifampin in treatment of meningococcal carriers.N Engl J Med. 1969 Sep 18;281(12):641-5. doi: 10.1056/NEJM196909182811203. N Engl J Med. 1969. PMID: 4980025 Clinical Trial. No abstract available.
-
"Remarkable improvement": sulfa drugs and pediatric meningococcal meningitis, 1937-1949.Pediatrics. 2011 Jun;127(6):1011-3. doi: 10.1542/peds.2010-2744. Epub 2011 May 2. Pediatrics. 2011. PMID: 21536616 Review. No abstract available.
-
[Neisseria meningitidis].Bacteriol Virusol Parazitol Epidemiol. 1992 Jan-Jun;37(1-2):3-29. Bacteriol Virusol Parazitol Epidemiol. 1992. PMID: 1472777 Review. Romanian. No abstract available.
Cited by
-
Homogeneity of protein serotype antigens in Neisseria meningitidis group A.Infect Immun. 1977 May;16(2):623-7. doi: 10.1128/iai.16.2.623-627.1977. Infect Immun. 1977. PMID: 405327 Free PMC article.